These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 36004515)

  • 1. Differentiating primary dry eye disease from ocular neuropathic pain: implications for symptom management.
    Forristal MT; Stephenson KAJ
    Clin Exp Optom; 2023 Aug; 106(6):605-611. PubMed ID: 36004515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain.
    Ozen S; Ozer MA; Akdemir MO
    Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1173-1177. PubMed ID: 28299439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete response to artificial tears is associated with features of neuropathic ocular pain.
    Galor A; Batawi H; Felix ER; Margolis TP; Sarantopoulos KD; Martin ER; Levitt RC
    Br J Ophthalmol; 2016 Jun; 100(6):745-9. PubMed ID: 26377416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Mirogabalin on Hyperalgesia and Chronic Ocular Pain in Tear-Deficient Dry-Eye Rats.
    Kikuchi K; Tagawa Y; Murata M; Ishida S
    Invest Ophthalmol Vis Sci; 2023 May; 64(5):27. PubMed ID: 37233999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dry eye disease: identification and therapeutic strategies for primary care clinicians and clinical specialists.
    Sheppard J; Shen Lee B; Periman LM
    Ann Med; 2023 Dec; 55(1):241-252. PubMed ID: 36576348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is gabapentin effective in dry eye disease and neuropathic ocular pain?
    Ongun N; Ongun GT
    Acta Neurol Belg; 2021 Apr; 121(2):397-401. PubMed ID: 31134508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining Dry Eye from a Clinical Perspective.
    Tsubota K; Pflugfelder SC; Liu Z; Baudouin C; Kim HM; Messmer EM; Kruse F; Liang L; Carreno-Galeano JT; Rolando M; Yokoi N; Kinoshita S; Dana R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33291796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dry Eye Disease: Early Recognition with Guidance on Management and Treatment for Primary Care Family Physicians.
    Verjee MA; Brissette AR; Starr CE
    Ophthalmol Ther; 2020 Dec; 9(4):877-888. PubMed ID: 33090327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Self-Report of Severity of Ocular Pain Due to Light as a Predictor of Altered Central Nociceptive System Processing in Individuals With Symptoms of Dry Eye Disease.
    Rodriguez DA; Galor A; Felix ER
    J Pain; 2022 May; 23(5):784-795. PubMed ID: 34890797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of central sensitisation in those with dry eye symptoms and neuropathic-like ocular pain complaints: incomplete response to topical anaesthesia and generalised heightened sensitivity to evoked pain.
    Crane AM; Feuer W; Felix ER; Levitt RC; McClellan AL; Sarantopoulos KD; Galor A
    Br J Ophthalmol; 2017 Sep; 101(9):1238-1243. PubMed ID: 28100479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropathic ocular pain: an important yet underevaluated feature of dry eye.
    Galor A; Levitt RC; Felix ER; Martin ER; Sarantopoulos CD
    Eye (Lond); 2015 Mar; 29(3):301-12. PubMed ID: 25376119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix Metalloproteinase 9 Testing in Dry Eye Disease Using a Commercially Available Point-of-Care Immunoassay.
    Messmer EM; von Lindenfels V; Garbe A; Kampik A
    Ophthalmology; 2016 Nov; 123(11):2300-2308. PubMed ID: 27665213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular pain response to treatment in dry eye patients.
    Siedlecki AN; Smith SD; Siedlecki AR; Hayek SM; Sayegh RR
    Ocul Surf; 2020 Apr; 18(2):305-311. PubMed ID: 31931186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing self-reported optometric dry eye clinical practices in Australia and the United Kingdom: is there scope for practice improvement?
    Downie LE; Rumney N; Gad A; Keller PR; Purslow C; Vingrys AJ
    Ophthalmic Physiol Opt; 2016 Mar; 36(2):140-51. PubMed ID: 26890703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Dry Eye with Laryngopharyngeal Reflux in Clinical Practice.
    Bonini S; Labetoulle M; Messmer E; Aragona P; Benitez Castillo JM; Ciprandi G; Damiani V; Irkec M; Baudouin C; Rolando M
    Curr Eye Res; 2022 Feb; 47(2):214-219. PubMed ID: 34437824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dry Eye Disease in University-based Clinics in Canada: A Retrospective Chart Review.
    Bitton E; Elder M; Srinivasan S; Luensmann D; Jones LW
    Optom Vis Sci; 2020 Nov; 97(11):944-953. PubMed ID: 33110027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Nano-ophthalmology in Treating Dry Eye Disease.
    Natesan S; Boddu SHS; Krishnaswami V; Shahwan M
    Pharm Nanotechnol; 2020; 8(4):258-289. PubMed ID: 32600244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics of Dry Eye Patients With Chronic Pain Syndromes.
    Vehof J; Sillevis Smitt-Kamminga N; Kozareva D; Nibourg SA; Hammond CJ
    Am J Ophthalmol; 2016 Feb; 162():59-65.e2. PubMed ID: 26603488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the association between the severity of ocular and systemic pain.
    Yamanishi R; Uchino M; Kawashima M; Dogru M; Matsuguma S; Tsubota K
    Ocul Surf; 2019 Jul; 17(3):434-439. PubMed ID: 31152803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications.
    Patel S; Mittal R; Sarantopoulos KD; Galor A
    Expert Opin Ther Targets; 2022 Aug; 26(8):681-695. PubMed ID: 36069761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.